Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
Dimitra Vlachopoulou(Aristotle University of Thessaloniki), George Giannakoulas(AHEPA University Hospital), Αναστάσιος Κάρτας(Aristotle University of Thessaloniki), Dimitrios V. Moysidis(Aristotle University of Thessaloniki), Melina Kyriakou(Aristotle University of Thessaloniki), Αndreas S. Papazoglou(Aristotle University of Thessaloniki), Apostolos Tzikas(AHEPA University Hospital), Charalampos Balomenakis(Aristotle University of Thessaloniki), Ioannis Vouloagkas(Aristotle University of Thessaloniki), Athanasios Samaras(Aristotle University of Thessaloniki), Amalia Baroutidou(Aristotle University of Thessaloniki), Konstantinos Barmpagiannos(AHEPA University Hospital), Anastasios D. Papanastasiou(Aristotle University of Thessaloniki)
Cited by 4
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
|EP Europace|2019|323
COVID-19 in Adults With Congenital Heart Disease
|Journal of the American College of Cardiology|2021|76
Prognostic significance of diabetes mellitus in patients with atrial fibrillation
|Cardiovascular Diabetology|2021|48